William Blair Starts Agile Therapeutics (AGRX) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street dips as higher yields, rising oil prices mark shaky start to SeptemberÂ
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- The Warsh pivot markets didn't expect
Janney Starts Agile Therapeutics (AGRX) at Buy
June 17, 2014 7:23 AM EDTJanney Montgomery Scott initiated coverage on Agile Therapeutics (NASDAQ: AGRX) with a Buy rating and a price target of $18.00.
For an analyst ratings summary and ratings history on Agile Therapeutics click here. For more ratings news on Agile Therapeutics click here.
Shares of Agile Therapeutics closed at $6.78 yesterday.
... MoreCantor Fitzgerald Starts Agile Therapeutics (AGRX) at Buy
June 17, 2014 7:22 AM EDTCantor Fitzgerald initiated coverage on Agile Therapeutics (NASDAQ: AGRX) with a Buy rating and a price target of $17.00.
Analyst Irina Rivkind Koffler said, "Agile is developing Twirla, a Phase III, low-dose estrogen contraceptive patch... More
